Peer Review History
| Original SubmissionOctober 17, 2019 |
|---|
|
PONE-D-19-28795 Routinely MUAC screening for severe acute malnutrition should consider the gender and age group bias in the Ethiopian non-emergency context PLOS ONE Dear Dr Laillou, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
We would appreciate receiving your revised manuscript by Jan 13 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Samson Gebremedhin, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 3. Please include additional information regarding the parental consent obtained for this study. For example, were the parents well informed prior to consenting? 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately. These will be automatically included in the reviewers’ PDF.
Additional (section-by-section) Editor Comments: Background section
Methods section
Results
Discussion
Conclusion
[Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript deals with an important topic. The authors have made fundamental scientific mistakes by assuming weight for height as a gold standard and by trying to determine optimal cut offs by comparing the number of children detected by different anthropometric measures. The only way this can be achieved is by a study examining outcomes. Several studies have shown that weight for height and MUAC identify different groups of children and that MUAC has better predictive performance for mortality. Thus assuming weight for height as a gold standard is problematic because it has worse performance. The statement that switching to a MUAC based program would be unethical simply cannot be determined from the analysis that was done. It might be true, but it might also be true that a weight for height based program or a program based on both measures is unethical if it expends resources on a large number of children at low risk or it it fails to target those at greatest risk of death or neurodevelopment consequences. The other issues of ethical importance are coverage and cost benefit since unlimited resources will not be available and would need to be addressed in policy making decisions. Overall the findings of how the two measures identify different populations in Ethiopia is of some interest in determining caseloads of potential different policies. The current WHO guidelines suggest using either measure but analysis of outcomes has led to a proposal that using a higher MUAC cutoff value would have better performance. Although the authors also suggest this, it should also only be based on a study that determines outcomes. Reviewer #2: Routinely MUAC screening for severe acute malnutrition should consider the gender and age group bias in Ethiopian non-emergency context. General comments. The issue, of whether to use Weight-for-height or MUAC is still hotly debated, so far so that one has “believers” and “non-believers”. This is mainly because there is never going to be a way to solve this issue. Firstly, what one is doing, is evaluating a screening tool to decide which one is best. This qualitative appraisal is done using sensitivity and specificity analyses and likelihood ratios to evaluate the text from a clinical perspective. The primary condition for this evaluation is that we “know” who is ill. Or to put it in another way ; that we know who is malnourished. Problem here is that we decide on this using an indicators that we are trying to evaluate. Here MUAC is evaluated against weight-for-height, or vice-versa. The flaw is that we are evaluating one indicator against another one without having a definition of who is really malnourished. We miss a “Golden Standard”. The comparisons done in this present paper are therefore not very useful. Moreover, they say what many other papers have said already. Both indices find other populations and the overlap is small. The second issue, is that arguments in favour of one or the other indicator are based on analyses of risk of mortality. Some studies find that MUAC is more predictive for mortality and hence should be used. The flaw here is that malnutrition is taken as an exposure variable, where it is rather an effect of a multi-causal problem. There a many different reasons why a child could be malnourished, and it is these reasons that are responsible for the increased mortality risk, and not the weight loss per sé. Using malnutrition, based on an indicator, to predict mortality , is therefore not entirely correct from a strict epidemiological point of view. So what can the authors do? They should have analysed more directly the effect of using a MUAC with single cut-off irrespective of gender. They should have done this using anthro and calculating the age and gender specific z-scores. Then they could have compared the misclassification comparing MUAC single cut-off with MUAC gender and age specific and distribution cut-off. This would have been more informative. The question of the study should have been whether to use MUAC with a single cut-off or use an age and gender specific one. More specific comments I have the impression that the authors have treated this “lightly” and not invested a lot in the existing literature. Moreover, on the HWO site is a useful systematic review on the matter: https://www.who.int/nutrition/publications/guidelines/updates_management_SAM_infantandchildren_review1.pdf The paper would have benefitted from a more exhaustive literature evaluation. Line 108. The Youden index is not correctly defined. It is not de difference between Se and SP; but rather Se+Sp minus 1. How is accuracy measured and defined?? The rate in line 109 is not a rate, because the is no incidence and time line. Table 2 is not useful , see my first main comment. The same goes for the AUC analyses. Line 124: the figures are not corresponding to the figures. Line 138. The false positive rates and the health post activities are not clearly explained. Is it because in the field MUAC is used , to be confirmed at the health post by Weight-for-height? In that case , indeed a lot of false positive will be identified. This is something to be avoided because it decrease the confidence the population will have in the health care providers. They go the health centre because they are told something is wrong with their child to be told late that there is no problem. The next time this happens, they will not go to the health centre again , because there previous experience thought them that nothing will happen. Late on, the authors use the higher sensitivity of MUAC to justify its use; forgetting the false positives at the health centre will have very important negative effects on health system appreciation. Line 187- 191 The discussion This should be more focussed on the main question: MUAC one for all or a age and gender specific cut-off. The argument of mortality should be re-evaluated against the second main comment I made. Line 166: Why are logistic problem a challenge for MUAC??? Line 167: why is it a more “robust” screening tool??? Line 172: reference ? Please also evaluated the quality of the surveys by giving an idea of the standard deviations as in the paper by Grellety. PLoS One. 2016 Dec 28;11(12):e0168585. doi: 10.1371/journal.pone.0168585. eCollection 2016. The Effect of Random Error on Diagnostic Accuracy Illustrated with the Anthropometric Diagnosis of Malnutrition. Grellety E1, Golden MH2. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: James A Berkley Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Routinely MUAC screening for severe acute malnutrition should consider the gender and age group bias in the Ethiopian non-emergency context PONE-D-19-28795R1 Dear Dr. Laillou, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Samson Gebremedhin, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-28795R1 Routinely MUAC screening for severe acute malnutrition should consider the gender and age group bias in the Ethiopian non-emergency context Dear Dr. Laillou: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Samson Gebremedhin Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .